# The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy

> **NCT00600691** · PHASE2 · TERMINATED · sponsor: **University of British Columbia** · enrollment: 29 (actual)

## Conditions studied

- Hematuria
- Hematospermia

## Interventions

- **DRUG:** Finasteride

## Key facts

- **NCT ID:** NCT00600691
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-03
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** Did not achieve enrollment goal and decided to terminate early
- **Last updated:** 2014-01-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00600691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00600691, "The Use of Finasteride to Reduce Hematuria and Hematospermia Following TRUS Prostate Biopsy". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00600691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*